The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers
It’s a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.
An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician-entrepreneur and executive director of the MIT Center for Biomedical Innovation.
The authors are calling for a new “science of collaboration” to learn what works and doesn’t work; to improve how leaders can design, manage and evaluate collaborations; and to help educate and train future leaders with the necessary organizational and managerial skills.
“Getting new, better, affordable drugs to the right patients faster involves a series of historically independent decisions made by different players or stakeholders,” says Hirsch. The system is uncoordinated, takes too long, and costs too much. In some cases, the drug—such as new antibiotics for life-threatening resistant infections—may never become available.
“One of the interesting paradoxes of biomedical innovation is increasingly going to be that even though we have the scientific knowledge required to provide potentially better treatments for patients—or even to prevent disease in those who are at high risk—we may be unable to help patients benefit from them anytime soon,” she says.
To help change this scenario, in the last decade, thousands of researchers, pharmaceutical and biotechnology companies, government regulators, payers, clinicians and patients have come together in more than 100 multi-stakeholder collaborations to solve some specific shared problem standing in the way of finding a cure or a better diagnostic approach.
“Multi-stakeholder collaborations provide the opportunity to create an environment that allows for new kinds of interactions among the players,” Hirsch says. The largest multi-stakeholder effort, the European Union’s Innovative Medicines Initiative (IMI) began in 2008 and has established more than 40 consortia with financial and in-kind investments totaling €2 billion. Some projects focus on specific health issues, such as Alzheimer’s disease, chronic pain, diabetes and obesity. Others tackle bigger issues, such as drug and vaccine safety and the use of stem cells for drug discovery. The success has led to a proposal to extend the effort for 10 years and €3.5 billion. Last year, the U.S. President’s Council of Advisors on Science and Technology (PCAST) recommended the U.S. form something similar.
“The prevalence of multi-stakeholder initiatives reflects a continued optimism about the value of this collaboration approach for addressing biomedical innovation bottlenecks,” the authors write in the paper. “Although the need for collaboration is no longer in question, it is worth noting the importance of this development. A willingness to share proprietary data among industry competitors represents a dramatic shift in the culture of the historically highly competitive pharmaceutical industry.”
The article reviews the history of collaborations beginning with HIV/AIDS. By the early 2000s, multi-stakeholder collaborations proliferated to address the need for important tools, such as biomarkers, that require preclinical data sharing. Since then, they have reached to encompass later stages in product development, including manufacturing, reimbursement and post-market monitoring.
Some people involved in multi-stakeholder consortia are concerned about redundancy, inefficiency and lack of productivity of some collaborative efforts, all contributing to a sense of “consortium fatigue,” the researchers write.
In a newer trend, funders and participants are seeking a smaller number of strategically coordinated initiatives that will reliably address critical gaps, Hirsch and Papadaki write. They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
The authors propose a rigorous evidence-based approach (the science of collaboration) to figure out what works and doesn’t work in collaborations. They recommend early steps in this new field and structuring the research to help learn from the past but also to evolve effectively as new innovation challenges emerge.
The Latest Bing News on:
Science of collaboration
- Queen Mary University of London Signs New Agreement with UESTC, Strengthening International Collaborationon May 10, 2024 at 6:31 pm
The signing of the 4+1 Progression Agreement marked UESTC’s first visit to Queen Mary since 2017. Both partners further explored opportunities to broaden and deepen the universities’ institutional re ...
- Collaborative partnership improves veterinary shortageon May 10, 2024 at 12:30 pm
Evette’s staffing services matches relief veterinarians and veterinary technicians with positions and clinics that align with their skills and passion. They offer a 24/7 a personal booking agent to ...
- Data science CDT puts industry collaboration at its hearton May 10, 2024 at 6:01 am
The Liverpool Centre for Doctoral Training (CDT) for Innovation in Data Intensive Science is preparing the next generation of physicists for their future careers ...
- Oregon State seeks long-term partners for AI collaborationon May 10, 2024 at 12:01 am
Oregon State's College of Engineering is soliciting partners from industry for AI projects. The college has positioned itself as Portland industry’s partner of choice, and it has been at the forefront ...
- Highfield Hall Will Present Art/Science Collaboration 'In Flux'on May 9, 2024 at 9:00 pm
Perspectives on Arctic Change,” is scheduled to open on Tuesday, May 21. The exhibition, sponsored by Woodwell Climate Research Center, features selections ...
- Collaboration uncovers an entirely new COVID-related syndromeon May 9, 2024 at 9:55 am
Pradipta Ghosh, M.D., sat down in her office at the University of California San Diego School of Medicine and considered a request from the other side of the world.
- UTSA to buy property next to School of Data Science downtown from GrayStreeton May 8, 2024 at 11:19 am
The University of Texas at San Antonio plans to buy nearly 1.5 acres downtown next to its School of Data Science and National Security Collaboration Center.
- Bridging the Gap for Food Systems Transformation: New European Network of Academic Collaboration on Food Systems Scienceon May 7, 2024 at 8:34 am
Europe’s food system is affected by complex challenges, such as meeting the demands for sustainable food production, distribution and consumption, ...
- Building a secure culture of safety in health and science constructionon May 6, 2024 at 12:14 am
Healthcare facility sites can present significant logistical and safety challenges, requiring innovative approaches, consistency in protocols and clear communication.
- Here’s What the Science of Reading Looks Like in My High School Classroomon May 3, 2024 at 11:02 am
Teachers can design lessons around these five components to deepen student understanding of and engagement with reading material.
The Latest Google Headlines on:
Science of collaboration
[google_news title=”” keyword=”Science of collaboration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Biomedical innovation
- New biomedical engineering innovation shows potential to transform trauma care and surgical practiceson May 10, 2024 at 9:32 pm
A breakthrough study, published in Science Translational Medicine , features a biomedical engineering innovation with the potential to transform trauma care and surgical practices. Chapman ...
- Elected officials, university representatives break ground for ‘extraordinary’ Biomedical Campuson May 10, 2024 at 3:43 pm
More than 100 people gathered at the intersection of Topeka and William on Wednesday morning to celebrate the groundbreaking for the Wichita Biomedical Campus, a collaborative initiative that aims to ...
- Neurology Educator Honored With AAN Innovation Awardon May 10, 2024 at 12:31 pm
Amit Kandel, MD, MBA, associate professor of neurology, has been honored by the American Academy of Neurology (AAN) with its 2024 Clerkship Director Innovation Award.
- Dal startup space partners with province to boost biomedical innovationon May 10, 2024 at 4:30 am
The Emera ideaHUB on Dal's downtown Sexton Campus will receive new funding from the Government of Nova Scotia to support startups focused on health care-related products and technologies.
- Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Updateon May 9, 2024 at 3:05 pm
Phase 2b ODYSSEY Trial in Wet AMD Remains on Track with Topline Data Expected Q3 2024 -- Strengthened Management Team and Board of Directors ...
- Groundbreaking held for Wichita Biomedical Campuson May 9, 2024 at 2:07 pm
Hundreds of people gathered May 8 to celebrate the start of phase one construction on the new Wichita Biomedical Campus, a $300 million, 471,000-square-foot joint health sciences center in the ...
- Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conferenceon May 8, 2024 at 1:14 pm
ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), ...
- KU, Wichita State break ground on Wichita biomedical campuson May 8, 2024 at 12:30 pm
WICHITA — Governor Laura Kelly on Wednesday joined higher education leaders from the University of Kansas, Wichita State University and WSU Tech to break ground on the new $302 million Wichita ...
- Canadian Hub for Health Intelligence and Innovation in Infectious Diseases awarded $72 millionon May 6, 2024 at 1:47 pm
Four research programs in the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI 3) have received $72 million in federal funding from the Canada Biomedical Research Fund ...
- Pennington Biomedical Research Center Named a Spoke in the ARPA-H Investor Catalyst Hubon May 6, 2024 at 12:17 pm
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
The Latest Google Headlines on:
Biomedical innovation
[google_news title=”” keyword=”biomedical innovation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]